COVID-19 booster shots, future applications of mRNA technology

Andreas Milano

April 27, 2021 1 min read ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . “ data-action=”subscribe”> Subscribe We were unable to process […]

April 27, 2021

1 min read

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]

In a recent article, experts discussed whether people may need booster doses of the messenger RNA vaccines to combat variants and prolong protection against wild-type SARS-CoV-2. It was the top story in infectious disease last week.

Another top story examined how past successes in vaccine research and billions of dollars in public funds led to the development of messenger RNA (mRNA) COVID-19 vaccines in record time, and what this could mean for vaccines against other diseases.

Source: Adobe Stock

Read these and more top stories in infectious disease below:

Will we need COVID-19 booster shots?

Data suggest that the mRNA-based COVID-19 vaccines developed by Pfizer-BioNTech and Moderna provide protection from infection for at least 6 months. Recent comments made by the heads of two of those companies raised questions about whether people may need booster doses of the vaccines. Read more.

Past research and ‘unlimited resources’ spur fast development of COVID-19 vaccines

When scientists began working on solutions for the COVID-19 pandemic in early 2020, it seemed unlikely that a safe and effective vaccine would be available in a year, according to Paul A. Offit, MD. Yet, by mid-December, the FDA had authorized two mRNA vaccines developed by Pfizer-BioNTech and Moderna for emergency use after researchers found they were more than 90% efficacious in late-stage trials — data now backed up by real-world evidence. Read more.

COVID-19 outbreak at skilled nursing facility linked to unvaccinated worker

Researchers identified an unvaccinated, symptomatic health care worker as the index patient in a COVID-19 outbreak at a skilled nursing facility in Kentucky that totaled 46 cases, many of them among fully vaccinated residents and staff. Read more.

Rollout lacks message that COVID-19 vaccination ‘will change your life

In a recent Infectious Diseases Society of America press briefing, Amesh A. Adalja, MD, senior scholar at the Johns Hopkins Center for Health Security, said most vaccine hesitancy is a result of misinformation. Read more.

European regulators recommend adding blood clot warning to J&J vaccine

European regulators said that a warning about unusual blood clots with low blood platelets should be added to information about the Johnson & Johnson COVID-19 vaccine but also that the benefits of the vaccine outweigh the risks. Read more.

Next Post

Unisoc unveils new Tanggula T740, T760, and T770 5G chipsets

Most of you are familiar know about MediaTek, Qualcomm, and Samsung chipsets. But what about smaller companies like Unisoc? Unisoc is a Chinese chipset manufacturer and it just announced its new Tanggula 7 series, which are 5G chipsets for mid-range devices. According to Gizchina, the Tanggula 7 series has three […]